Adcock Ingram Holdings Ltd (AIPJ.J)

AIPJ.J on Johannesburg Stock Exchange

5,200.00ZAc
27 Mar 2015
Change (% chg)

3.00c (+0.06%)
Prev Close
5,197.00c
Open
5,200.00c
Day's High
5,246.00c
Day's Low
5,186.00c
Volume
1,213,885
Avg. Vol
422,608
52-wk High
6,480.00c
52-wk Low
4,046.00c

AIPJ.J

Chart for AIPJ.J

About

Adcock Ingram Holdings Limited is a South Africa-based manufacturer of pharmaceuticals. The Company is also a manufacturer, marketer and distributor of healthcare products. It is a supplier of hospital and critical care products. Its product portfolio includes branded and generic prescription medicines, over the counter... (more)

Overall

Beta: 0.58
Market Cap(Mil.): R9,138.55
Shares Outstanding(Mil.): 175.74
Dividend: --
Yield (%): --

Financials

  AIPJ.J Industry Sector
P/E (TTM): -- 29.41 41.35
EPS (TTM): -- -- --
ROI: -- 10.00 59.33
ROE: -- 11.42 66.96
Search Stocks

BRIEF-Adcock gets firm intention to make offer from Bidvest

* Board of directors of Adcock has consented to release of restrictions on dividend shares subject to terms

12 Mar 2015

S.Africa's Bidvest, PIC in talks to jointly control half of Adcock

JOHANNESBURG, March 11 - South Africa's Bidvest Group is in talks with a fellow shareholder in Adcock Ingram, the Public Investment Corporation (PIC), to jointly control nearly half of struggling drugmaker, it said on Wednesday.

11 Mar 2015

South Africa Bidvest CEO expects major Adcock shareholder to reject bid

JOHANNESBURG - The chief executive of South Africa's Bidvest Group said his $515 million buyout offer for Adcock Ingram is likely to be rejected by a major shareholder, meaning the industrial conglomerate could end up with less than 100 percent.

02 Mar 2015

Bidvest makes $515 million bid for rest of Adcock Ingram

JOHANNESBURG - South African conglomerate Bidvest has offered about $515 million for the shares it does not already own in drugmaker Adcock Ingram in a new attempt to build a big presence in the pharmaceutical market.

23 Feb 2015

BRIEF-S Africa's Bidvest proposes to acquire drugmaker Adcock Ingram

* Proposed offer by Bidvest to acquire up to 100 pct of Adcock Ingram Holdings Limited ("Adcock")

23 Feb 2015

BRIEF-Adcock Ingram posts 38 pct rise in H1 HEPS

* H1 gross profit 993.027 million rand (not 993 027 rand), up 3 pct

23 Feb 2015

BRIEF-Adcock Ingram sees July-Dec HEPS of 81-84 cents per share

* Sees HEPS for July-Dec of 81-84 cents per share Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

18 Feb 2015

BRIEF-Adcock posts quarterly profit of about R50 mln

* Made approximately R50 mln profit after tax in three month period ended 30 september 2014

21 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00
Provider: MarketLine (a Datamonitor Company)
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks